این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
مجله علمی دانشگاه علوم پزشکی بیرجند، جلد ۱۵، شماره ۲، صفحات ۲۹-۳۶
عنوان فارسی مقایسه متوپرولول و کارودیلول در درمان بیماران با نارسایی قلبی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله متوپرولول، کارودیلول، نارسایی قلبی، بتابلوکر
عنوان انگلیسی Comparison of carvedilol and metoprolol in heart failure management
چکیده انگلیسی مقاله Background and Aim: Heart failure is one of the most prevalent diseases with high mortality and disability. Beta blockers are among basic drugs treating the disorder and leading to reduction in cardiovascular mortality, and improvement of symptoms and left ventricular function. Regarding the increasing prevalence of this disease, the present study was carried out to compare carvedilol with metoprolol in the treatment of patients with heart-failure. Material and Methods: In this analytical and prospective study, which was carried out between March 2005 and June 2006, 73 patients with advanced heart failure (ejection fraction=EF= %30-35%) and functional class (FC) I to III were followed up for 6 months. 38 cases of the patients received metoprolol tartrate and 33 cases received carvedilol. Clinical data and left ventricular (LV) function indices before and after treatment as shown in echocardiography were recorded in a questionnaire. Then, these changes were compared statistically by means of SPSS (11.5). Results: Mean age of the patients in the metprolol group was 576.6 and in the carvedilol was 56.87.3 years. Average daily dose of metoprolol and carvedilol was 75 mg and 25 mg respectively. Heart rate and blood pressure reduction due to respective treatments (NYHA class) Improvement was similar in two groups. Functional class of patients in both groups improved one degree (P< 0.001) .In metoprolol treated patients. Left Ventricular End Diastolic Diameter (LEDD) and Left Ventricular End Systolic Diameter (LVESD) reductions were 8.7mm and 2.3mm (P< 0.001, P< 0.001) as well as Left Ventricular End Diastolic Volume (LVEDV) and Left Ventricular End Systolic (LVES) reductions were 4.3 cc and 7.3 cc (P=0.008, P< 0.001), respectively. Mean EF increased 3.3%. (P=0.000). In carvedilol treated patients LEDD and LESD reduced 2.78 mm (P< 0.001) and 1.57 mm (P=0.045) and LVEDV & LVES reduced 2.3 cc (P=0.53) and 7.3 cc (P=0.007), respectively, and mean EF Increased 2.2% (P=0.004). There were no statistically significant differences between the two groups. Conclusion: In heart failure patients with FC I to III both metoprolol tartrate and carvedilol administration improves symptoms of the disease and LV function. In this study no significant differences were observed between the effects of the two drugs.
کلیدواژه‌های انگلیسی مقاله Carvedilol, Metoprolo, Heart failure, Beta blocker
نویسندگان مقاله هما فال سلیمان | h fal soleiman
مشهد- بیمارستان قائم عج - بخش قلب

افسانه محمدی | a. mohammadi


نشانی اینترنتی http://journal.bums.ac.ir/browse.php?a_code=A-10-1-266&slc_lang=fa&sid=fa
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده fa
موضوعات مقاله منتشر شده قلب وعروق
نوع مقاله منتشر شده تجربی
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات